“At abcam, we put in an enormous amount of work into confirming the specificity of the antibodies,” Solache explains. The company uses knock-out cell lines to eliminate doubts about cross ...

Recombinant antibody development is set to revolutionize biomedical innovation. It has the prospective to transform both diagnostics and medication. Abcam recombinant antibodies can pave the way ...

The IWGAV recommended application testing and knock-out validation as key pillars for the validation of RUO antibodies 4, which Abcam has been doing for many years. The company has now raised the ...

Simon Thompson: It’s benefiting from a rising gold price and a customer base impacted by the rising cost ...